Introduction
HER2-positive breast cancer accounts for nearly 1 in 5 breast cancer cases worldwide, and its treatment often relies on Trastuzumab, a life-saving monoclonal antibody therapy. However, the original brand (Herceptin®) remains costly for many healthcare systems and patients globally.
India, known for its high-quality yet affordable biosimilar manufacturing, has become the leading global exporter of Trastuzumab biosimilars such as Herzuma, Vivitra, Canmab, and Ogivri — ensuring accessibility for hospitals and patients worldwide.
At the heart of this export network is Unnati Pharmax, a trusted oncology medicine supplier and exporter that delivers authentic, WHO-GMP-approved HER2 biosimilars across the Philippines, UAE, Germany, UK, and Africa.
Understanding HER2 Biosimilars
HER2 biosimilars are clinically tested, biologically equivalent alternatives to the original Herceptin®.
They offer the same therapeutic benefits but at a significantly lower cost, making advanced cancer therapy accessible for more patients.
Benefits of Trastuzumab Biosimilars:
- ✅ Comparable efficacy & safety to Herceptin®
- 💸 60–80% lower cost than the original
- 🌍 Available for global procurement
- 🏥 Approved by multiple international health authorities
Top HER2 Biosimilars Exported from India by Unnati Pharmax
India manufactures multiple approved Trastuzumab biosimilars, all compliant with WHO-GMP and national regulatory standards.
Here are the most in-demand HER2-targeted medicines exported globally:
💉 1. Herzuma (Trastuzumab 440 mg Injection)
Manufacturer: Celltrion Healthcare / Glenmark (India supply version)
Use: HER2-positive breast and gastric cancer
Form: Lyophilized powder for injection (440 mg / vial)
Export Markets: Philippines 🇵🇭, UAE 🇦🇪, Germany 🇩🇪, Kenya 🇰🇪, UK 🇬🇧
Indicative Price Range: $180–$350 per vial
Why It’s in Demand:
- One of the most prescribed biosimilars globally
- Affordable, approved, and trusted alternative to Herceptin®
- Preferred in hospital oncology tenders
👉 Order Herzuma safely through Unnati Pharmax Shop.
💉 2. Vivitra (Trastuzumab 440 mg Injection)
Manufacturer: Zydus Cadila
Use: Breast and gastric cancer
Form: Injection, 150 mg / 440 mg vials
Markets: UAE 🇦🇪, Philippines 🇵🇭, Nigeria 🇳🇬, Germany 🇩🇪
Price Range: $150–$320 per vial
Highlights:
- Clinically equivalent to Herceptin®
- Widely used in oncology hospitals
- Cost-effective bulk availability
💉 3. Canmab (Trastuzumab 440 mg)
Manufacturer: Biocon Biologics
Use: HER2-positive metastatic breast cancer
Markets: UAE, Germany, Philippines, UK
Price Range: $170–$300 per vial
💉 4. Ogivri (Trastuzumab)
Manufacturer: Mylan / Biocon
Use: Breast & gastric cancer treatment
Markets: Germany 🇩🇪, UAE 🇦🇪, Philippines 🇵🇭
Price Range: $180–$350 per vial
Why It’s Trusted:
- Globally approved biosimilar
- Meets EU & USFDA equivalence standards
Indicative Price Comparison
| Medicine (Trastuzumab Brand) | Branded Price (USD) | Unnati Pharmax Export Price (USD) |
|---|---|---|
| Herceptin 440 mg (Original) | $800–$1200 | Contact Us.— |
| Herzuma 440 mg | — | Contact Us. |
| Vivitra 440 mg | — | Contact Us. |
| Canmab 440 mg | — | Contact Us. |
💡 Prices are indicative; for official bulk quotes, visit Contact Us.
Unnati Pharmax: Your Trusted Oncology Export Partner
At Unnati Pharmax, we ensure genuine oncology supply to hospitals, distributors, and clinics globally.
Our priority is quality assurance, affordability, and global accessibility for critical treatments like Trastuzumab.
🌍 Why Choose Unnati Pharmax:
- 100% authentic WHO-GMP-certified biosimilars
- Bulk & retail export options
- Documentation for customs & compliance
- Global logistics with cold-chain integrity
- Quick response & personalized quotation support
Unnati Pharmax works with oncology hospitals, NGOs, and healthcare procurement agencies to deliver life-saving cancer therapies worldwide.
Global Demand for Trastuzumab Biosimilars
- 🌍 India exports Trastuzumab biosimilars to 80+ countries.
- 💊 Global HER2 market expected to reach USD 12 billion by 2030.
- 📦 Cost savings from biosimilars exceed 70% vs. branded Herceptin®.
- 🇵🇭 The Philippines ranks among the highest importers of Trastuzumab from India.
- 🇦🇪 The UAE and Middle East oncology demand is growing rapidly due to affordable Indian biosimilars.
- 🇩🇪 Germany and Europe source biosimilars from India for cost efficiency and regulatory compliance.
Export Documentation & Compliance
Unnati Pharmax ensures full documentation for international oncology exports:
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Batch release documents
- Commercial invoice & packing list
- Cold chain management for all biologics
We ensure temperature-controlled transport for all biologics, including Herzuma, Vivitra, and Canmab.
How to Place an International Order
- 🛒 Visit Unnati Pharmax Shop
- 📋 Select your required oncology biosimilars
- ✉️ Submit your bulk enquiry or single order
- 📑 Receive official quotation and documentation
- 🚚 Get secure international delivery (5–12 working days)
We support B2B tenders, bulk orders, and B2C purchases globally.
Frequently Asked Questions (FAQs)
1. Do you export Trastuzumab biosimilars to hospitals and distributors?
Yes, Unnati Pharmax supplies to hospitals, government tenders, and distributors worldwide.
2. Are these biosimilars WHO-GMP approved?
Absolutely. All products are sourced from certified Indian manufacturers with full approvals.
3. Can individuals order a single vial of Herzuma?
Yes. We supply both bulk and individual orders with safe, cold-chain packaging.
4. What countries do you ship to?
We export to 100+ countries, including the Philippines, UAE, Germany, UK, and Africa.
5. Are these products authentic and safe?
Yes, all oncology medicines from Unnati Pharmax are authentic, batch-verified, and quality-tested.
External References
- World Health Organization – Breast Cancer Overview
- FDA India – Trastuzumab Biosimilar Approvals
- European Medicines Agency – Biosimilar Guidelines
- Healthline – HER2 Breast Cancer Treatment
- National Cancer Institute – Trastuzumab Information
Related Blogs
- Prostate Cancer Medicines Export from India: Indenza, Abiraterone & Global Market Demand
- Kidney Cancer Medicines Export from India: Affordable Oncology Supply Worldwide
- Top Cancer Medicines Exported from India: Global Demand & Pricing Guide
- Hepatitis Medicines Export from India: Global Market & Buyer’s Guide
🚀 Conclusion
With Unnati Pharmax, hospitals and distributors around the world can now access affordable HER2 biosimilars like Herzuma, Vivitra, and Canmab, sourced directly from India’s trusted oncology manufacturers.
Our mission is simple — to make life-saving breast cancer treatments accessible, authentic, and affordable globally.
📞 Get in Touch for Bulk or Single Orders:
👉 https://unnatipharmax.com/contact-us/
💊 Unnati Pharmax — Empowering Oncology Access, One Medicine at a Time.

Add comment